Unknown

Dataset Information

0

Targeting Forward and Reverse EphB4/EFNB2 Signaling by a Peptide with Dual Functions.


ABSTRACT: The tyrosine kinase receptor EphB4 is frequently overexpressed in ovarian and other solid tumors and is involved in interactions between tumor cells and the tumor microenvironment, contributing to metastasis. Trans-interaction between EphB4 and its membrane-bound ligand ephrin B2 (EFNB2) mediates bi-directional signaling: forward EFNB2-to-EphB4 signaling suppresses tumor cell proliferation, while reverse EphB4-to-EFNB2 signaling stimulates the invasive and angiogenic properties of endothelial cells. Currently, no small molecule-based, dual-function, EphB4-binding peptides are available. Here, we report our discovery of a bi-directional ephrin agonist peptide, BIDEN-AP which, when selectively internalized via receptor-mediated endocytosis, suppressed invasion and epithelial-mesenchymal transition of ovarian cancer cells. BIDEN-AP also inhibited endothelial migration and tube formation. In vivo, BIDEN-AP and its nanoconjugate CCPM-BIDEN-AP significantly reduced growth of orthotopic ovarian tumors, with CCPM-BIDEN-AP displaying greater antitumor potency than BIDEN-AP. Both BIDEN-AP and CCPM-BIDEN-AP compromised angiogenesis by downregulating epithelial-mesenchymal transition and angiogenic pathways. Thus, we report a novel EphB4-based therapeutic approach against ovarian cancer.

SUBMITTER: Xiong C 

PROVIDER: S-EPMC6965176 | biostudies-literature | 2020 Jan

REPOSITORIES: biostudies-literature

altmetric image

Publications

Targeting Forward and Reverse EphB4/EFNB2 Signaling by a Peptide with Dual Functions.

Xiong Chiyi C   Wen Yunfei Y   Zhao Jun J   Yin Dengke D   Xu Lingyun L   Chelariu-Raicu Anca A   Yao Cody C   Leng Xiaohong X   Liu Jinsong J   Chaudhari Rajan R RR   Zhang Shuxing S   Sood Anil K AK   Li Chun C  

Scientific reports 20200116 1


The tyrosine kinase receptor EphB4 is frequently overexpressed in ovarian and other solid tumors and is involved in interactions between tumor cells and the tumor microenvironment, contributing to metastasis. Trans-interaction between EphB4 and its membrane-bound ligand ephrin B2 (EFNB2) mediates bi-directional signaling: forward EFNB2-to-EphB4 signaling suppresses tumor cell proliferation, while reverse EphB4-to-EFNB2 signaling stimulates the invasive and angiogenic properties of endothelial ce  ...[more]

Similar Datasets

| S-EPMC4403310 | biostudies-other
| S-EPMC4089464 | biostudies-literature
| S-EPMC6192726 | biostudies-literature
| S-EPMC1895526 | biostudies-literature
| S-EPMC5456102 | biostudies-literature
| S-EPMC2645496 | biostudies-other
| S-EPMC6546932 | biostudies-literature
| S-EPMC4035936 | biostudies-literature
| S-EPMC3401278 | biostudies-literature
| S-EPMC5904292 | biostudies-literature